War on Fake Drugs
22 01 2008Bilcare Ltd a leading pharmaceutical packaging and clinical research company has acquired a Singapore based company named Singular ID, for Rs 55 crores ($19.58 billion). The acquisition made through its wholly-owned subsidiary, Bilcare Singapore Pte, represents a significant step forward in ongoing war against counterfeit drugs and pharmaceuticals products.
For complete story downloadwar-on-fake-drugs.pdf
